The V-ATPase inhibitor archazolid
Fighting metastasis is a major challenge in cancer therapy and novel therapeutic targets and drugs are highly appreciated. Resistance of invasive cells to anoikis, a particular type of apoptosis induced by loss of cell-extracellular matrix (ECM) contact, is a major prerequisite for their metastatic...
Main Author: | Schempp, Christina Maria |
---|---|
Format: | Others |
Published: |
Ludwig-Maximilians-Universität München
2014
|
Subjects: | |
Online Access: | http://edoc.ub.uni-muenchen.de/16858/1/Schempp_Christina_M.pdf http://nbn-resolving.de/urn:nbn:de:bvb:19-168586 |
Similar Items
-
Anticancer effects of the V-ATPase inhibitor Archazolid B
by: Wiedmann, Romina Madeleine
Published: (2011) -
Mechanism of cancer evading metronomic chemotherapy and action of Archazolid as an anti-metastatic drug
by: Kubisch, Rebekka
Published: (2013) -
Anti-angiogenic effects of cytotoxic, microbial derived compounds - Evaluation of the tubulin inhibitor pretubulysin and its derivatives and characterization of the v-ATPase inhibitor concanamycin A
by: Rath, Sebastian
Published: (2012) -
Die Funktion der ABC-ATPase Rli1p in der Translation
by: Maertens, Birgit
Published: (2007) -
X-Ray Structures of the Sulfolobus solfataricus SWI2/SNF2 ATPase Core and its Complex with DNA
by: Dürr, Harald
Published: (2005)